SCHEMBL8945895

SCHEMBL8945895

CNC(c1ccsc1)C(N)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.46
TDO2 P48775 1/20 0.46
DPP4 P27487 2/20 0.42
ALOX5 P09917 1/20 0.34
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
SLC6A3 Q01959 2/20 0.34
KCNH2 Q12809 1/20 0.34
ADRA2C P18825 2/20 0.33
F2 P00734 1/20 0.33
CHRM2 P08172 1/20 0.33
ADRA1A P35348 1/20 0.33
CYP2E1 P05181 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2B6 P20813 1/20 0.33
RGS12 O14924 1/20 0.33
GLA P06280 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866367 0.82 DPP4 (0.56) DPP4SLC6A2SLC6A4CYP3A4CYP2D6
SCHEMBL14455234 0.82 DPP4 (0.56) DPP4SLC6A2SLC6A4CYP3A4CYP2D6
SCHEMBL24017126 0.80 CYP3A4 (0.43) IDO1TDO2ALOX5SLC6A2SLC6A4
SCHEMBL24017044 0.80 CYP3A4 (0.43) IDO1TDO2ALOX5SLC6A2SLC6A4
SCHEMBL8946044 0.75 DPP4 (0.43) DPP4ALOX5SLC6A2SLC6A4CYP3A4
SCHEMBL9425803 0.72 CYP3A4 (0.62) DPP4SLC6A2SLC6A4CYP3A4CYP2D6
SCHEMBL23967163 0.72 ALOX5 (0.41) IDO1TDO2ALOX5SLC6A2SLC6A4
SCHEMBL10588478 0.71 DPP4 (0.39) DPP4ALOX5
SCHEMBL24017145 0.69 IDO1 (0.45) IDO1TDO2DPP4ALOX5KCNH2
SCHEMBL24017064 0.69 IDO1 (0.45) IDO1TDO2DPP4ALOX5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5510346-A ANTIDEPRESSANTS, ANTIANXIETY AGENTS HOECHST MARION ROUSSEL, INC. (US) 1996-04-23 US disclosed
EP-0322582-A2 4-Heteroaryl-1,3-Benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-07-05 EP disclosed